P.O. Box 3660, Riyadh 11481, Mail Code 1515 (KAIMRC)
+966 (11) 429-4444
+966 (11) 429-4440

Publication

This publication highlighted the establishment of a Stem Cell Research and Regenerative Medicine program at KAIMRC to coordinate advanced stem cell research and translational
outcomes with the goal of treating chronic human diseases, such as cancer, diabetes, cardiovascular, neurological, immunological, and liver diseases.

Name of Article:

Stem cell research and regenerative medicine at King Abdullah International Medical Research Center

Author(s):

Abumaree, M. H., Al Askar, A. S., Kalionis, B., Abomaray, F. M., Jawdat, D., et al.

Journal:

Stem Cells and Development

Year of Publication:

2014

Publication Issue:

23

Page Numbers:

12-16

Impact Factor:

3.727

Affiliation:

King Saud Bin Abdulaziz University for Health Sciences, College of Science and Health Professions, Riyadh, Kingdom of Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Kingdom of Saudi Arabia; King Saud Bin Abdulaziz University for Health Sciences, College of Medicine, Riyadh, Kingdom of Saudi Arabia; Department of Obstetrics and Gynecology and Department of Perinatal Medicine, University of Melbourne, Pregnancy Research Center, Royal Women’s Hospital, Parkville, Victoria, Australia.

Shortlink:

bit.ly/1ipyPfG

Abstract:

Translation of stem cell research from bench to bedside opens up exciting new therapeutic options for patients. Although stem cell research has progressed rapidly, its clinical applications have not kept pace. We report on the establishment of a stem cell research and regenerative medicine program at King Abdullah International Medical Research Center (KAIMRC). The purpose of this unit is to coordinate advanced stem cell research and translational outcomes with the goal of treating chronic human diseases, such as cancer, diabetes, cardiovascular, neurological, immunological, and liver diseases. Our first step in achieving this goal was to integrate the stem cells and regenerative medicine unit with our umbilical cord blood bank and bone marrow registry. This organizational structure will provide different sources for stem cells for research and clinical purposes, and facilitate our stem cell research and stem cell transplantation program. We are at an early and exciting stage in our program, but we believe that our progress to the international stage will be rapid and have a significant impact.